Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.34p
   
  • Change Today:
      0.000p
  • 52 Week High: 0.88
  • 52 Week Low: 0.23
  • Currency: UK Pounds
  • Shares Issued: 742.72m
  • Volume: 0
  • Market Cap: £2.49m
  • RiskGrade: 435

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Gerald Desler 128,668 £431

Major Shareholders

Notifier** Holding Value*
Jaspal Singh 33,500,000 £112,225
Mark Eccleston 22,746,187 £76,200
Adam Hargreaves 7,749,163 £25,960
SANDERSON CAPITAL PARTNERS LTD 5,000,000 £16,750
Monecor (London) Limited 3,520,629 £11,794
Spreadex Ltd 2,222,840 £7,446
Paul Richards 722,533 £2,420
Cairn Financial Advisers LLP 332,308 £1,113
Jarvis Investment Management Ltd 129,436 £434
Peter James Crowson 3,383 £11

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.34p
Change Today 0.000p
% Change 0.00 %
52 Week High 0.88
52 Week Low 0.23
Volume 0
Shares Issued 742.72m
Market Cap £2.49m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.52% above the market average41.52% above the market average41.52% above the market average41.52% above the market average41.52% above the market average
46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average
Price Trend
87.83% below the market average87.83% below the market average87.83% below the market average87.83% below the market average87.83% below the market average
81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average
Income Not Available
Growth
26.62% above the market average26.62% above the market average26.62% above the market average26.62% above the market average26.62% above the market average
31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average

Valirx Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Valirx Key Personnel

CFO Gerald Desler

Top of Page